Sequential Prostate Magnetic Resonance Imaging in Newly Diagnosed High-Risk Prostate Cancer Treated with Neoadjuvant Enzalutamide is predictive of therapeutic response

PURPOSE: For high-risk prostate cancer, standard treatment options include radical prostatectomy (RP) or radiation therapy plus androgen-deprivation therapy (ADT). Despite definitive therapy, many patients will have disease recurrence. Imaging has the potential to better define characteristics of re...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Cancer Res
Prif Awduron: Karzai, Fatima, Walker, Stephanie M., Wilkinson, Scott, Madan, Ravi A., Shih, Joanna H., Merino, Maria J., Harmon, Stephanie A., VanderWeele, David J., Cordes, Lisa M., Carrabba, Nicole V., Bright, John R., Terrigino, Nicolas T., Chun, Guinevere, Bilusic, Marijo, Couvillon, Anna, Hankin, Amy, Williams, Monique N., Lis, Rosina T., Ye, Huihui, Choyke, Peter L., Gulley, James L., Sowalsky, Adam G., Turkbey, Baris, Pinto, Peter A., Dahut, William L.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7855232/
https://ncbi.nlm.nih.gov/pubmed/33023952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-2344
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg